tadalafil has been researched along with canagliflozin in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (canagliflozin) | Trials (canagliflozin) | Recent Studies (post-2010) (canagliflozin) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 998 | 194 | 975 |
| Protein | Taxonomy | tadalafil (IC50) | canagliflozin (IC50) |
|---|---|---|---|
| Sodium/glucose cotransporter 1 | Homo sapiens (human) | 0.9497 | |
| Sodium/glucose cotransporter 2 | Homo sapiens (human) | 0.0039 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aal, FAM; Ali, ABH; Mohamed, AI; Rageh, AH | 1 |
1 other study(ies) available for tadalafil and canagliflozin
| Article | Year |
|---|---|
Cytochrome P450 3A4-mediated pharmacokinetic interaction study between tadalafil and canagliflozin using high-performance thin-layer chromatography.
Topics: Canagliflozin; Chromatography, Thin Layer; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Erectile Dysfunction; Humans; Male; Tadalafil | 2022 |